Thallium-201²⁰¹Tl-chloride
A potassium analog with redistribution, legacy cardiac, viability, and tumor agent
Quick Answer
Thallium-201 is a potassium analog taken up by viable myocardium (and other cells) via the Na⁺/K⁺-ATPase, in proportion to blood flow. Its defining feature is redistribution: initial uptake reflects perfusion, but over hours thallium washes in and out so that viable-but-underperfused ("hibernating") myocardium fills in on delayed/reinjection imaging. Largely superseded by Tc-99m agents for routine perfusion (low-energy emissions, higher dose), it retains value for myocardial viability.
Mechanism
Active transport via the Na⁺/K⁺-ATPase (potassium analog); continuous exchange with the blood pool drives redistribution over ~3–24 h. Initial distribution tracks perfusion; the delayed distribution tracks viability (cell-membrane integrity), which is why a fixed early defect that later fills in indicates living, not scarred, tissue.
Biodistribution & Physics
Myocardium, skeletal muscle, kidneys, thyroid, and gut. The low-energy characteristic X-rays (69–80 keV) and 73-hour half-life mean higher radiation dose and poorer image quality/attenuation than Tc-99m (140 keV) — the principal reasons for its decline in routine MPI.
Clinical Indications
- Myocardial viability: stress–redistribution–reinjection protocols; delayed fill-in indicates viable, hibernating myocardium.
- Historic myocardial perfusion imaging (now mostly Tc-99m or PET).
- Legacy parathyroid and brain-tumor imaging (now other agents).
Protocol Notes
- Typical activity ~3–4 mCi; LEHR collimator; low-energy window (~70 keV X-rays ± 167 keV γ).
- Stress → redistribution (3–4 h) → ± reinjection for viability; late (24 h) imaging in some protocols.
- Because thallium redistributes, timing is intrinsic to interpretation (unlike sestamibi).
Interpretation Highlights
- Redistribution/fill-in of a stress defect = viability; a persistent (fixed) defect that does not fill in after reinjection = scar.
- Reverse redistribution (a defect that appears/worsens on delayed images) — variable significance (post-revascularization, artifact, or subendocardial injury).
- Increased lung uptake — a marker of stress-induced LV dysfunction / high-risk disease.
Reporting Checklist
- State the protocol (stress–redistribution–reinjection; delayed imaging).
- Report fill-in vs fixed defects (viability), TID, and lung uptake (high-risk sign).
- Note attenuation/low-count limitations of the low-energy emissions.
Common Pitfalls
- Calling a fixed thallium defect "scar" without redistribution/reinjection imaging (underestimates viability).
- Attenuation and low-count artifacts from the low-energy emissions.
- Misreading reverse redistribution as significant without context.
Board Pearls
Thallium-201 is a potassium analog taken up by viable myocytes (Na⁺/K⁺-ATPase) in proportion to flow, and its defining feature is redistribution: initial uptake reflects perfusion, but delayed/reinjection imaging shows viable-but-hibernating myocardium filling in. Redistribution = viability — a fixed defect that fills in is viable, not scar.
Increased lung uptake on thallium is a high-risk marker (stress-induced LV dysfunction). Low-energy X-ray emissions (69–80 keV), a 73-h half-life, and higher dose (poorer images/attenuation than Tc-99m) explain why thallium is now a viability, not routine-perfusion, agent.
Interpretation depends on protocol and timing because thallium redistributes (unlike sestamibi's minimal redistribution). Beware reverse redistribution — a delayed defect of variable significance. Alternatives for viability include FDG-PET perfusion–metabolism mismatch (reference standard), Tc-99m gated wall-thickening, and CMR late-gadolinium transmurality.
Related Pages
- Protocol: Myocardial viability; contrast tracer: sestamibi/tetrofosmin (minimal redistribution).
- Related: Nuclear cardiology overview, MPI SPECT; pitfalls: Pearls, pitfalls & normal variants.
Figure / Diagram Suggestions
- A redistribution time-course schematic (perfusion early → viability late).
- A fill-in vs fixed defect teaching pair (viable vs scar).
- A lung-uptake high-risk illustration.
Self-Check
Q1. What does redistribution of a stress thallium defect indicate?
Answer: Viability — a defect that fills in on delayed/reinjection imaging is viable (hibernating) myocardium, not scar.
Q2. Why has thallium been largely replaced by Tc-99m agents for routine perfusion?
Answer: Its low-energy X-rays (69–80 keV), long 73-h half-life, and higher radiation dose give poorer images/attenuation than Tc-99m (140 keV).
Q3. What does increased lung uptake on a thallium study signify?
Answer: A high-risk marker of stress-induced LV dysfunction.
Q4. A fixed thallium defect is called "scar" without reinjection imaging. What is the error?
Answer: It underestimates viability — a fixed early defect may fill in after reinjection/redistribution, indicating viable myocardium.
Evidence & sources
https://nuc.med/thallium-201/ Report an issue